Related Experiment Video
Updated: Sep 25, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Survival analysis among pediatric patients receiving kidney replacement therapy: a Japanese nationwide cohort study
Daishi Hirano1, Eisuke Inoue2, Mayumi Sako3
1Department of Pediatrics, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan. bqx1976@hotmail.com.
Insights
Pediatric patients with chronic kidney disease (CKD) stage 5 on kidney replacement therapy (KRT) in Japan show high survival rates, but infants (<1 year) face significantly lower survival. Improvements in infant dialysis are needed.
Area of Science:
- Nephrology
- Pediatric Medicine
- Public Health
Background:
- Limited data exist on survival and causes of death for pediatric patients with chronic kidney disease (CKD) stage 5 undergoing kidney replacement therapy (KRT) in Asia.
- This study addresses this gap by analyzing data from Japan.
Purpose of the Study:
- To evaluate the survival rates and causes of death in pediatric patients (<20 years) with CKD stage 5 receiving KRT in Japan.
- To identify factors influencing survival, particularly age at KRT initiation.
Main Methods:
- A nationwide cross-sectional survey of pediatric patients starting KRT between 2006 and 2013 in Japan.
- Cohort divided into age groups: <1 year, 1-5 years, and 6-19 years at KRT initiation.
Main Results:
- Overall 1-year and 5-year survival rates were 97.2% and 92.5%, respectively, among 701 pediatric patients.
- Infants (<1 year) had significantly lower survival rates (HR 5.35) compared to older children.
- Infection (35.9%) and sudden death (15.4%) were the leading causes of mortality.
Conclusions:
- Pediatric CKD stage 5 survival in Japan is comparable to other high-income countries.
- Age at KRT initiation is a critical factor, with infants experiencing the poorest outcomes.
- Enhanced dialysis strategies for infants are crucial to improve survival rates in the youngest pediatric population.
Background:
Limited data are available on the survival and causes of death in pediatric patients with chronic kidney disease (CKD) stage 5 receiving kidney replacement therapy (KRT) in Asia.
Methods:
Data were obtained from the Japanese nationwide cross-sectional CKD stage 5 survey on pediatric patients (<20 years of age) who started KRT from 2006 to 2013. The cohort was divided into three groups according to age at the start of KRT: <1, 1-5, and 6-19 years.
Results:
Among the 701 children who were included, 59.3% were boys. Peritoneal dialysis was the most common initial modality of KRT (60.3%). Median age at KRT initiation was 10.2 years. Infants (<1 year old) accounted for 16.0% of the total cohort. Overall survival at 1 and 5 years was 97.2% and 92.5%, respectively. Infants had significantly lower survival rates than the other groups (hazard ratio, 5.35; 95% CI, 2.60-11.03; P < 0.001). In contrast, after the age of 1 year, the survival rate improved and did not differ from that of other age groups. The most common causes of death were infection (35.9%) and sudden death (15.4%).
Conclusions:
The overall survival rate of pediatric patients with CKD stage 5 in Japan is like that in other high-income countries. Age at initiation of KRT is an important factor affecting survival since the poorest survival rate was observed in infants. Further improvement in infant dialysis therapy is still needed to improve survival of the youngest children. A higher resolution version of the Graphical abstract is available as Supplementary information.
Related Concept Videos
Kidney Transplant I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Continuous Renal Replacement Therapy
Acute Kidney Injury II: Pathophysiology
Kidney Transplant III: Nursing Management

